Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1967 Jan;26(1):1–9. doi: 10.1136/ard.26.1.1

Antinuclear factor in rheumatoid arthritis and related diseases.

D A Pitkeathly, G Taylor
PMCID: PMC1030992  PMID: 4163368

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALEXANDER W. R., BREMNER J. M., DUTHIE J. J. Incidence of the anti-nuclear factor in human sera. Ann Rheum Dis. 1960 Dec;19:338–350. doi: 10.1136/ard.19.4.338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BALL J. Serum factor in rheumatoid arthritis agglutinating sensitized sheep red cells. Lancet. 1950 Nov 11;2(6637):520–524. doi: 10.1016/s0140-6736(50)91500-5. [DOI] [PubMed] [Google Scholar]
  3. BARNETT E. V., CONDEMI J. J., LEDDY J. P., VAUGHAN J. H. GAMMA-2, GAMMA-1A AND GAMMA-1M ANTINUCLEAR FACTORS IN HUMAN SERA. J Clin Invest. 1964 Jun;43:1104–1115. doi: 10.1172/JCI104995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. CEPPELLINI R., POLLI E., CELADA F. A DNA-reacting factor in serum of a patient with lupus erythematosus diffusus. Proc Soc Exp Biol Med. 1957 Dec;96(3):572–574. doi: 10.3181/00379727-96-23544. [DOI] [PubMed] [Google Scholar]
  5. CHRISTIAN C. L., MENDEZ-BRYAN R., LARSON D. L. Latex agglutination test for disseminated lupus erythematosus. Proc Soc Exp Biol Med. 1958 Aug-Sep;98(4):820–823. doi: 10.3181/00379727-98-24195. [DOI] [PubMed] [Google Scholar]
  6. Condemi J. J., Barnett E. V., Atwater E. C., Jacox R. F., Mongan E. S., Vaughan J. H. The significance of antinuclear factors in rheumatoid arthritis. Arthritis Rheum. 1965 Dec;8(6):1080–1093. doi: 10.1002/art.1780080607. [DOI] [PubMed] [Google Scholar]
  7. FESSEL W. J. Nucleoprotein-latex agglutination test in connective tissue diseases. Ann Rheum Dis. 1959 Sep;18:255–258. doi: 10.1136/ard.18.3.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. FRIEDMAN I. A., SICKLEY J. F., POSKE R. M., BLACK A., BRONSKY D., HARTZ W. H., Jr, FELDHAKE C., REEDER P. S., KATZ E. M. The L.E. phenomenon in rheumatoid arthritis. Ann Intern Med. 1957 Jun;46(6):1113–1136. doi: 10.7326/0003-4819-46-6-1113. [DOI] [PubMed] [Google Scholar]
  9. GOSLINGS J., HIJMANS W., KIEVITS J. H., SCHUTT H. R. Rheumatoid arthritis and the positive L.E.-cell phenomenon. Ann Rheum Dis. 1956 Sep;15(3):211–216. doi: 10.1136/ard.15.3.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. HALL A. P., BARDAWIL W. A., BAYLES T. B., MEDNIS A. D., GALINS N. The relations between the antinuclear, rheumatoid and L.E.-cell factors in the systemic rheumatic diseases. N Engl J Med. 1960 Oct 20;263:769–775. doi: 10.1056/NEJM196010202631601. [DOI] [PubMed] [Google Scholar]
  11. HASERICK J. R., LEWIS L. A., BORTZ D. W. Blood factor in acute disseminated lupus erythematosus; determination of gamma globulin as specific plasma fraction. Am J Med Sci. 1950 Jun;219(6):660–663. doi: 10.1097/00000441-195006000-00010. [DOI] [PubMed] [Google Scholar]
  12. HIJMANS W., DONIACH D., ROITT I. M., HOLBOROW E. J. Serological overlap between lupus erythematosus, rheumatoid arthritis, and thyroid auto-immune disease. Br Med J. 1961 Oct 7;2(5257):909–914. doi: 10.1136/bmj.2.5257.909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. HOLBOROW E. J., WEIR D. M., JOHNSON G. D. A serum factor in lupus erythematosus with affinity for tissue nuclei. Br Med J. 1957 Sep 28;2(5047):732–734. doi: 10.1136/bmj.2.5047.732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. HOLMAN H. R., KUNKEL H. G. Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein. Science. 1957 Jul 26;126(3265):162–163. doi: 10.1126/science.126.3265.162. [DOI] [PubMed] [Google Scholar]
  15. KELLGREN J. H., BALL J. Clinical significance of the rheumatoid serum factor. Br Med J. 1959 Feb 28;1(5121):523–531. doi: 10.1136/bmj.1.5121.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. LEE R. C., EPSTEIN W. V. Hemagglutination study of serum factors related to L.E. cell formation. Arthritis Rheum. 1960 Feb;3:41–48. doi: 10.1002/art.1780030105. [DOI] [PubMed] [Google Scholar]
  17. MIESCHER P., STRASSLE R. New serological methods for the detection of the L.E. factor. Vox Sang. 1957 Sep;2(4):283–287. doi: 10.1111/j.1423-0410.1957.tb03704.x. [DOI] [PubMed] [Google Scholar]
  18. PEARSON C. M., CRADDOCK C. G., SIMMONS N. S. Complement fixation reactions with DNA and leukocyte material in systemic lupus erythematosus: correlation with the L. E. cell phenomenon and the clinical status. J Lab Clin Med. 1958 Oct;52(4):580–587. [PubMed] [Google Scholar]
  19. ROSS S. W., CLARDY E. K. The L.E. test in patients presenting the clinical picture of rheumatoid arthritis. South Med J. 1956 Jun;49(6):553–559. doi: 10.1097/00007611-195606000-00001. [DOI] [PubMed] [Google Scholar]
  20. ROTHFIELD N. F., PHYTHYON J. M., McEWEN C., MIESCHER P. The role of antinuclear reactions in the diagnosis of systemic lupus erythematosus: a study of 53 cases. Arthritis Rheum. 1961 Jun;4:223–239. doi: 10.1002/art.1780040302. [DOI] [PubMed] [Google Scholar]
  21. SELIGMANN M. Etudes immunologiques sur le lupus érythémateux disséminé. Rev Fr Etud Clin Biol. 1958 Jun;3(6):558–584. [PubMed] [Google Scholar]
  22. WARD D. J., JOHNSON G. D., HOLBOROW E. J. ANTINUCLEAR FACTOR IN RHEUMATOID ARTHRITIS, ITS INCIDENCE AND CLINICAL SIGNIFICANCE. Ann Rheum Dis. 1964 Jul;23:306–310. doi: 10.1136/ard.23.4.306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. WEIR D. M., HOLBOROW E. J., JOHNSON G. D. A clinical study of serum antinuclear factor. Br Med J. 1961 Apr 1;1(5230):933–937. doi: 10.1136/bmj.1.5230.933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. ZIFF M. The agglutination reaction in rheumatoid arthritis. J Chronic Dis. 1957 Jun;5(6):644–667. doi: 10.1016/0021-9681(57)90074-7. [DOI] [PubMed] [Google Scholar]
  25. ZINKHAM W. H., CONLEY C. L. Some factors influencing the formation of L.E. cells; a method for enhancing L.E. cell production. Bull Johns Hopkins Hosp. 1956 Feb;98(2):102–119. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES